Association between family history of dementia and hallucinations in Parkinson disease

Neurology

Volumn 64, Issue 10, 2005, Pages 1712-1715

  Paleacu, Diana ^a   Schechtman, Edna ^b   Inzelberg, Rivka ^c,d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HILLEL YAFFE MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; PARKIN;

AGED; ARTICLE; AUDITORY HALLUCINATION; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE DURATION; FAMILY HISTORY; FEMALE; HALLUCINATION; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; VISUAL HALLUCINATION;

AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEMENTIA; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC SCREENING; HALLUCINATIONS; HUMANS; LEVODOPA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 18844373289     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000161872.85903.8E     Document Type: Article

References (37)

1. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 2000;48:938-942.
2. Inzelberg R, Kipervasser S, Korczyn AD. Auditory hallucinations in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998;64:533-535.
3. Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain 2000; 123:733-745.
4. Fenelon G, Thobois S, Bonnet AM, Broussolle E, Tison F. Tactile hallucinations in Parkinson's disease. J Neurol 2002;249:1699-1703.
5. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-738.
6. Jimenez-Jimenez FJ, Orti-Pareja M, Gasalla T, et al. Cenesthetic hallucinations in a patient with Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:120.
7. Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001;70:727-733.
8. Goetz CG, Burke PF, Leurgans S, et al. Genetic variation analysis in Parkinson's disease patients with and without hallucinations. Arch Neurol 2001;58:209-213.
9. Inzelberg R, Paleacu P, Chapman J, Korzcyn AD. The apolipoprotein E ε4 allele increases the risk of drug-induced hallucinations in Parkinson's disease. Clin Neuropharmacol 2000;23:230-231.
10. Mouradian MM. Recent advances in the genetics and pathogenesis of Parkinson's disease. Neurology 2002;58:179-185.
11. Pankratz N, Nichols WC, Uniacke SK, et al. Significant linkage of Parkinson disease to chromosome 2q36-37. Am J Hum Genet 2003;72: 1053-1057.
12. Scott WK, Nance MA, Watts RL, et al. Complete genomic screening in Parkinson's disease. JAMA 2001;286:2239-2244.
13. Inzelberg R, Schecthman E, Paleacu D, et al., Onset and progression of disease in familial and sporadic Parkinson's disease. Am J Med Genet 2004;124:255-258.
14. Sweet RA, Nimgaonkar VL, Devlin B, Lopez OL, DeKosky ST. Increased familial risk of the psychotic phenotype of Alzheimer's disease. Neurology 2002;58:907-911.
15. Tunstall N, Owen MJ, Williams J, et al. Familial influence on variation in age of onset and behavioral phenotype in Alzheimer's disease. Br J Psychiatry 2000;176:156-159.
16. Tsuang D, Almqvist EW, Lipe H, et al. Familial aggregation of psychotic symptoms in Huntington's disease. Am J Psychiatry 2000;157: 1955-1959.
17. Calne DB, Snow BJ, Lee C. Criteria for the diagnosing Parkinson's disease. Ann Neurol 1992;32:S125-S127.
18. Marder K, Tang MX, Alfaro B, et al. Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology 1999;52:719-724.
19. Nisipeanu P, Inzelberg R, Abo Mouch S, et al. Parkin gene causing benign autosomal recessive juvenile parkinsonism. Neurology 2001;56: 573-575.
20. Inzelberg R, Hattori N, Nisipeanu P, et al. Camptocormia, axial dystonia, and parkinsonism: phenotypic heterogeneity of a parkin mutation. Neurology 2003;60:1393-1394.
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994.
22. Folstein MF, Folstein SE, Mc Hugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients of the clinician. J Psychiatry Res 1975;12:189-198.
23. McKeith LG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47:1113-1124.
24. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
25. Graham JM, Grunerwald RA, Sagar HJ. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:434-440.
26. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol 1996;53:1265-1268.
27. Goetz CG, Pappert EJ, Blasucci LM, et al. Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology 1998;50:515-517.
28. Turner TH, Cookson JC, Wass JAH, Drury PL, Price PA, Besser GM. Psychotic reactions during treatment of pituitary tumors with dopamine agonists. Br Med J 1984;289:1101-1103.
29. Broussole E, Defuentes G, Plauchu H, Chazot G. Frequence et profil clinique des formes familiales de la maladie de Parkinson. Rev Neurol 1995;153:406-411.
30. De la Fuente-Fernandez R, Sellers A, Beyer K, Lao JI. Apolipoprotein E genotype and age of onset of Parkinson's disease. Ann Neurol 1998;44: 294-295.
31. Inzelberg R, Paleacu D, Chapman J, Korczyn AD. Apolipoprotein E and Parkinson's disease. Ann Neurol 1998;44:294.
32. Bacanu SA, Devlin B, Chowdari KV, DeKosky ST, Nimnaonkar VL, Sweet EA. Linkage analysis of Alzheimer disease with psychosis. Neurology 2002;59:118-120.
33. Lovestone S, Hardy J. Psychotic genes or forgetful ones? Neurology 2002;59:11-12.
34. Makoff AJ, Greaham JM, Arranz MJ, et al. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics 2000; 10:43-48.
35. Kaiser R, Hofer A, Grapengiesser A, et al. L-Dopa induced adverse events in PD and dopamine transporter gene polymorphism. Neurology 2003;60:1750-1755.
36. Li Y-J, Scott WK, Hedges DJ, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 2002;70:985-993.
37. Tsuang DW, Di Giacomo L, Bird TD. Familial occurrence of dementia with Lewy bodies. Am J Geriatr Psychiatry 2004;12:179-188.